Vitamin B3, a water soluble vitamin essential to processing fat and proteins in the human body, may also prove…
Articles by Maureen Newman
Not all clinical trials vital to understanding Friedreich’s ataxia involve new therapies under evaluation before being marketed as treatment.
Patients with Friedreich’s ataxia commonly have difficulty walking due to imbalance issues or trouble conducting daily activities due to…
A large, international clinical trial sponsored by European Friedreich’s Ataxia Consortium for Translational Studies (EFACTS) is currently recruiting 650…
Friedreich’s ataxia patients are at a risk of developing foot drop deformity, or the loss of dorsiflexion and eversion…
When testing new compounds to treat Friedreich’s ataxia (FA), it is vital to have a metric for determining the…
Biopharmaceutical company Shire, is sponsoring a clinical trial for adults with Friedreich’s ataxia (FA) and is currently enrolling participants.
Although Friedreich’s ataxia is a condition with a known cause (a genetic abnormality on chromosome 9 that depletes cells…
Results are in for an open-label phase 2 clinical trial of interferon gamma (IFN-γ) treatment for Friedreich’s ataxia (FRDA)…